Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.78 USD | +0.53% | +9.88% | +164.34% |
Apr. 30 | Chromadex Corp. Announces an Ingredient Partnership with Solgar | CI |
Apr. 23 | Chromadex Announces Inaugural Major Grocery Debut of Tru Niagen® At Sprouts Farmers Market | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 256.8 | 297.5 | 255.8 | 125.4 | 107.7 | 285.4 | - | - |
Enterprise Value (EV) 1 | 256.8 | 297.5 | 255.8 | 125.4 | 107.7 | 285.4 | 285.4 | 285.4 |
P/E ratio | -7.7 x | -14.5 x | -9.35 x | -7 x | -20.4 x | 945 x | 65.7 x | 34.4 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 5.55 x | 5.02 x | 3.79 x | 1.74 x | 1.29 x | 2.94 x | 2.5 x | 2.07 x |
EV / Revenue | 5.55 x | 5.02 x | 3.79 x | 1.74 x | 1.29 x | 2.94 x | 2.5 x | 2.07 x |
EV / EBITDA | -12.7 x | -30.9 x | -13.5 x | -12.6 x | 56.7 x | 64.7 x | 22.5 x | 36.6 x |
EV / FCF | -12.2 x | -27.7 x | -10.4 x | -8.13 x | 15.4 x | 259 x | 33.6 x | 21.8 x |
FCF Yield | -8.21% | -3.61% | -9.61% | -12.3% | 6.47% | 0.39% | 2.98% | 4.59% |
Price to Book | 12.6 x | 18.1 x | 7.92 x | 4.37 x | - | - | - | - |
Nbr of stocks (in thousands) | 59,577 | 61,971 | 68,383 | 74,652 | 75,291 | 75,508 | - | - |
Reference price 2 | 4.310 | 4.800 | 3.740 | 1.680 | 1.430 | 3.780 | 3.780 | 3.780 |
Announcement Date | 3/10/20 | 3/10/21 | 3/9/22 | 3/8/23 | 3/6/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 46.29 | 59.26 | 67.45 | 72.05 | 83.57 | 97.09 | 114.3 | 137.9 |
EBITDA 1 | -20.17 | -9.615 | -18.9 | -9.973 | 1.9 | 4.41 | 12.66 | 7.8 |
EBIT 1 | -31.3 | -19.85 | -27.07 | -18.63 | -5.599 | -1.899 | 4.348 | 9.4 |
Operating Margin | -67.62% | -33.5% | -40.14% | -25.85% | -6.7% | -1.96% | 3.8% | 6.82% |
Earnings before Tax (EBT) 1 | -32.15 | -19.92 | -27.13 | -16.54 | -4.938 | -1.089 | 3.617 | 9.4 |
Net income 1 | -32.15 | -19.92 | -27.13 | -16.54 | -4.938 | -1.809 | 4.465 | 9.4 |
Net margin | -69.45% | -33.62% | -40.22% | -22.96% | -5.91% | -1.86% | 3.91% | 6.82% |
EPS 2 | -0.5600 | -0.3300 | -0.4000 | -0.2400 | -0.0700 | 0.004000 | 0.0575 | 0.1100 |
Free Cash Flow 1 | -21.08 | -10.74 | -24.57 | -15.43 | 6.969 | 1.1 | 8.5 | 13.1 |
FCF margin | -45.53% | -18.13% | -36.43% | -21.42% | 8.34% | 1.13% | 7.44% | 9.5% |
FCF Conversion (EBITDA) | - | - | - | - | 366.79% | 24.94% | 67.11% | 167.95% |
FCF Conversion (Net income) | - | - | - | - | - | - | 190.36% | 139.36% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/10/20 | 3/10/21 | 3/9/22 | 3/8/23 | 3/6/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 17.31 | 17.76 | 17.26 | 16.73 | 17.06 | 21 | 22.56 | 20.32 | 19.5 | 21.2 | 23.61 | 23.7 | 24.22 | 25.57 | 28.29 |
EBITDA 1 | -6.261 | -3.449 | -4.474 | -4.643 | -1.206 | 0.35 | -0.069 | 0.218 | 0.504 | 1.247 | 0.065 | 0.16 | 1.84 | 2.345 | 2.76 |
EBIT 1 | -8.841 | -5.316 | -7.732 | -6.387 | -3.065 | -1.444 | -1.968 | -2.316 | -1.147 | -0.168 | -1.742 | -1.237 | 0.315 | 0.79 | 0.67 |
Operating Margin | -51.08% | -29.93% | -44.8% | -38.17% | -17.96% | -6.88% | -8.72% | -11.4% | -5.88% | -0.79% | -7.38% | -5.22% | 1.3% | 3.09% | 2.37% |
Earnings before Tax (EBT) 1 | -8.856 | -5.325 | -7.74 | -6.397 | -0.985 | -1.418 | -1.902 | -2.191 | -0.959 | 0.114 | -1.707 | -1.027 | 0.6567 | 1.022 | 0.7 |
Net income 1 | -8.856 | -5.325 | -7.74 | -6.397 | -0.985 | -1.418 | -1.902 | -2.191 | -0.959 | 0.114 | -1.552 | -1.394 | 0.4825 | 0.9838 | 0.82 |
Net margin | -51.17% | -29.98% | -44.85% | -38.23% | -5.77% | -6.75% | -8.43% | -10.78% | -4.92% | 0.54% | -6.58% | -5.88% | 1.99% | 3.85% | 2.9% |
EPS 2 | -0.1300 | -0.0800 | -0.1100 | -0.0900 | -0.0100 | -0.0200 | -0.0300 | -0.0300 | -0.1000 | - | -0.0120 | -0.006000 | 0.0100 | 0.0160 | 0.0100 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/3/21 | 3/9/22 | 5/12/22 | 8/10/22 | 11/2/22 | 3/8/23 | 5/10/23 | 8/9/23 | 11/8/23 | 3/6/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | -21.1 | -10.7 | -24.6 | -15.4 | 6.97 | 1.1 | 8.5 | 13.1 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | 0.3400 | 0.2700 | 0.4700 | 0.3800 | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 0.75 | 0.14 | 0.41 | 0.33 | 0.15 | 0.51 | 0.51 | 0.9 |
Capex / Sales | 1.63% | 0.24% | 0.61% | 0.46% | 0.18% | 0.53% | 0.45% | 0.65% |
Announcement Date | 3/10/20 | 3/10/21 | 3/9/22 | 3/8/23 | 3/6/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+164.34% | 285M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- CDXC Stock
- Financials ChromaDex Corporation